Protease Inhibitors [clinicaltrials_resource:bd458628804b4d5762575e9ef3be9215]
condition [clinicaltrials_vocabulary:condition]
Interactions of HIV Protease Inhibitors and Methadone in HIV-Infected Patients [clinicaltrials:NCT00000906]A Study on Amprenavir in Combination With Other Anti-HIV Drugs in HIV-Positive Patients [clinicaltrials:NCT00000912]A Study of the Effectiveness of Different Anti-HIV Treatments in HIV-Positive Individuals Who Have Been on a Protease Inhibitor-Containing Drug Regimen for at Least 16 Weeks [clinicaltrials:NCT00000914]A Study to Evaluate Various Combinations of Anti-HIV Medications to Treat Early HIV Infection [clinicaltrials:NCT00000919]A Study to Compare Two Different Anti-HIV Drug Regimens [clinicaltrials:NCT00000924]A Study to Compare the Effectiveness of Different Anti-HIV Drug Regimens in Keeping Levels of HIV in the Blood as Low as Possible [clinicaltrials:NCT00000939]A Study on Possible Interactions Between Protease Inhibitors (Anti-HIV Drugs) and Drugs Which Lower the Level of Fat in Your Blood [clinicaltrials:NCT00000941]Safety and Effectiveness of Four Anti-HIV Drug Combinations in HIV-Infected Children and Teens [clinicaltrials:NCT00001091]A Phase I /II Study of the Protease Inhibitor Indinavir (MK-0639) in Children With HIV Infection [clinicaltrials:NCT00001443]Observation of HIV-Infected Children Receiving Protease Inhibitor and Reverse Transcriptase Inhibitor [clinicaltrials:NCT00001826]A Dose-Escalating Study of Ro 31-8959 ( HIV Protease Inhibitor ) in Patients With HIV Disease. [clinicaltrials:NCT00002111]A Phase II, Stratified, Randomized, Double-Blind, Multi-Center Study of the Safety and Efficacy of Adefovir Dipivoxil (ADF) at Two Dose Levels in Triple Combination Therapies With Protease Inhibitors (PI) and Nucleoside Reverse Transcriptase Inhibitors (RTI) for the Treatment of HIV-Infected Patient [clinicaltrials:NCT00002184]Safety and Effectiveness of Giving Two Nucleoside Reverse Transcriptase Inhibitors Alone or in Combination With 141W94 to HIV-Infected Children Who Have Never Received Protease Inhibitors [clinicaltrials:NCT00002193]A Comparison of 141W94 and Indinavir in HIV-Infected Patients [clinicaltrials:NCT00002202]A Study of Two Anti-HIV Drug Combinations [clinicaltrials:NCT00002203]An Open-Label Study to Evaluate the Efficacy and Safety of Amprenavir (141W94) and Abacavir Combination Therapy in Protease Inhibitor Experienced Subjects With HIV-1 Infection Who Are Failing Their Current Antiretroviral Treatment Regimen [clinicaltrials:NCT00002205]The Safety and Effectiveness of 1592U89 Plus 141W94 Plus DMP 266 in Patients With HIV Who Developed a Resistance to Protease Inhibitors [clinicaltrials:NCT00002213]A Randomized, Double-Blind Study of MKC-442 Combined With Viracept in Patients Who Are Epivir + Retrovir Experienced and Are Protease Inhibitor- and Non-Nucleoside Reverse Transcriptase Inhibitor-Naive [clinicaltrials:NCT00002215]A Study on the Safety and Effectiveness of Twice-Daily Nelfinavir Plus Twice-Daily Indinavir Plus Efavirenz in HIV-Positive Patients Who Have Never Taken Non-Nucleoside Reverse Transcriptase Inhibitors (NNRTIs) or Protease Inhibitors [clinicaltrials:NCT00002235]Study of a New Protease Inhibitor, BMS-232632, in Combination With Other Anti-HIV Drugs [clinicaltrials:NCT00002240]A Study of the Effects of Amprenavir, a Protease Inhibitor, on Carbohydrate and Fat Metabolism in HIV-Infected Patients [clinicaltrials:NCT00002245]Safety and Effectiveness of an Anti-HIV Drug Combination in HIV-Positive Patients Who Have Failed Previous Treatment With Protease Inhibitors [clinicaltrials:NCT00002361]A Study of Amprenavir in HIV-Infected Patients [clinicaltrials:NCT00002405]Comparing FTC and Lamivudine in HIV-Infected Patients on a Stable Anti-HIV Drug Combination [clinicaltrials:NCT00002416]A Study of Amprenavir in Patients With Protease Inhibitor-Related Complications [clinicaltrials:NCT00002417]The Safety and Effectiveness of Didanosine Plus Stavudine Plus Nevirapine Combined With MKC-442 in HIV-Infected Patients Who Have Not Had Success With Protease Inhibitors [clinicaltrials:NCT00002418]Safety and Effectiveness of Giving Adefovir Dipivoxil Plus Abacavir Plus Efavirenz Plus Amprenavir to HIV-Infected Patients Who Have Failed to Respond to Previous Protease Inhibitor Treatment [clinicaltrials:NCT00002419]The Safety and Effectiveness of Didanosine Plus Stavudine Plus Delavirdine Mesylate Plus MKC-442 in HIV-Infected Patients Who Have Not Had Success With Protease Inhibitors [clinicaltrials:NCT00002420]A Study of 1592U89 in Combination With Protease Inhibitors in HIV-Infected Patients Who Have Never Taken Anti-HIV Drugs [clinicaltrials:NCT00002440]A Study of ABT-378/Ritonavir Combination in HIV-Infected Patients Who Have Taken Protease Inhibitors [clinicaltrials:NCT00004580]A Study to Compare Two Anti-HIV Drug Combinations in HIV-Infected Patients Who Have Previously Received Anti-HIV Treatment [clinicaltrials:NCT00004581]ABT-378/Ritonavir and Efavirenz in HIV-Infected Patients Who Have Taken More Than One Protease Inhibitor in the Past [clinicaltrials:NCT00004582]Safety and Effectiveness of a New Protease Inhibitor, BMS-232632, in HIV-Positive Patients Who Have Received Previous Treatment [clinicaltrials:NCT00004584]Effects of Two Anti-HIV Drug Combinations on the Immune Systems of HIV-Infected Patients Who Have Never Received Anti-HIV Drugs [clinicaltrials:NCT00004855]Safety and Effectiveness of a Combination Anti-HIV Drug Treatment [clinicaltrials:NCT00005018]Effects of Topical SLPI on Skin Wounds [clinicaltrials:NCT00005569]Drug Interactions of Amprenavir and Efavirenz, in Combination With a Second Protease Inhibitor, in HIV-Negative Volunteers [clinicaltrials:NCT00005762]A Study to Evaluate the Use of a Protease Inhibitor and of Interleukin-2 (IL-2) in the Treatment of Early HIV Infection [clinicaltrials:NCT00006154]Atazanavir Used in Combination With Other Anti-HIV Drugs in HIV-Infected Infants, Children, and Adolescents [clinicaltrials:NCT00006604]Comparison of Three Different Initial Treatments Without Protease Inhibitors for HIV Infection [clinicaltrials:NCT00013520]
intervention browse [clinicaltrials_vocabulary:intervention-browse]
Protease Inhibitors [clinicaltrials_resource:bd458628804b4d5762575e9ef3be9215]
Bio2RDF identifier
bd458628804b4d5762575e9ef3be9215
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:bd458628804b4d5762575e9ef3be9215
identifier
clinicaltrials_resource:bd458628804b4d5762575e9ef3be9215
title
Protease Inhibitors
@en
type
label
Protease Inhibitors [clinicaltrials_resource:bd458628804b4d5762575e9ef3be9215]
@en